16. Pulpotomy (CH) versus pulpotomy (MTA + NaOCl).
Outcome | Time point (months) | No. of studies | Risk ratio (95% CI) |
Clinical failure | 6 | 1 | Not estimable* |
12 | 1 | 3.00 (0.13, 70.92) | |
Radiological failure | 6 | 1 | 5.00 (0.62, 40.36) |
12 | 1 | 8.00 (1.06, 60.21) | |
Soft tissue pathology | 6 | 1 | Not estimable* |
12 | 1 | 3.00 (0.13, 70.92) | |
Pathologic mobility | 6 and 12 | 1 | Not estimable* |
Adjacent tissue inflammation | 6 and 12 | 1 | Not estimable* |
Pathologic radiolucency | 6 | 1 | Not estimable* |
12 | 1 | 15.00 (0.89, 251.77) | |
Pathologic root resorption | 6 | 1 | Not estimable* |
12 | 17.00 (1.02, 282.30) | ||
Pulp canal obliteration | 6 | 1 | Not estimable* |
12 | 1 | 1.33 (0.52, 3.39) |
*due to lack of events
Abbreviations ‐ CI: confidence interval; CH: calcium hydroxyde; MTA: mineral trioxide aggregate; NaOCl; sodium hypochlorite.